Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 6, 2001, Pages 617-625

  Stern, Mariana C ^a   Umbach, David M ^a   Yu, Mimi C ^b   London, Stephanie J ^a   Zhang, Zhen Quan ^c   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Guangxi Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; HEPATITIS B SURFACE ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; GENETIC VARIABILITY; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AFLATOXIN B1; CARCINOMA, HEPATOCELLULAR; CHINA; DIET; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENVIRONMENTAL EXPOSURE; GENES, P53; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INCIDENCE; LIVER NEOPLASMS; POINT MUTATION;

EID: 0034905993     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Hepatitis B virus and the prevention of primary cancer of the liver
2. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
3. Molecular and genetic epidemiology of hepatocellular carcinoma: Studies in China and Senegal
4. Report on an IARC working group meeting on some naturally occurring substances
5. Aflatoxins
6. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
7. Aflatoxins as risk factors for hepatocellular carcinoma in humans
8. Mechanisms of aflatoxin carcinogenesis
9. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
10. A serological case-control study of primary hepatocellular carcinoma in Guangxi, China
11. Risk assessment for aflatoxin: II. Implications of human epidemiology data
12. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
13. Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity
14. p53 mutations in nonmalignant human liver: Fingerprints of aflatoxins?
15. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
16. Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis B virus and aflatoxin contamination in the diet
17. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
18. Aberrations of p53 gene in human hepatocellular carcinoma from China
19. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
20. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa
21. p53 mutations in hepatocellular carcinoma after aflatoxin exposure
22. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal
23. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
24. Base substitution mutations induced by metabolically activated aflatoxin B1
25. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens
26. Aflatoxin B1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
27. Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure
28. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
29. Hepatocellular carcinoma: From gene to public health
30. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
31. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1
32. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis
33. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice
34. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
35. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice
36. Hepatitis B virus, X protein inhibits nucleotide excision repair
37. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene
38. Mutations of p53 in hepatocellular carcinomas in Taiwan
39. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China
40. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China
41. Genetic heterogeneity of hepatocellular carcinoma
42. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people
43. Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas
44. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand
45. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico
46. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi autonomous region, People's Republic of China
47. Tutorial in biostatistics meta-analysis: Formulating, evaluating, combining, and reporting
48. p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection
49. p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China
50. c-myc gene and p53 protein expression in human primary liver carcinoma
51. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations
52. Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo
53. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice
54. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts
55. Hepatocellular carcinoma p53 G > T transversions at codon 249: The fingerprint of aflatoxin exposure?
56. Allele-specific, PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis
57. Genetic alterations in hepatocellular carcinomas: Association between loss of chromosome 4q and p53 gene mutations
58. p53 codon 249ser hot-spot mutation in HBV-negative hepatocellular carcinoma
59. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma
60. Infrequent mutation of p53 gene in hepatitis B virus-positive primary hepatocellular carcinomas
61. Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: Lack of association
62. p53 is not mutated in hepatocellular carcinomas from Alaska Natives
63. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas
64. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation
65. p53 mutations in human hepatocellular carcinomas from Germany
66. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event
67. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain
68. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation
69. The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma
70. Genetic changes and histopathological grades in human hepatocellular carcinomas
71. Aberrations of the tumor suppressor p53 retinoblastoma genes in human hepatocellular carcinomas
72. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
73. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
74. p53 gene mutation spectrum in hepatocellular carcinoma
75. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
76. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis
77. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore
78. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma